Moderna COVID-19 vaccine - Wikipedia
WEBThe Moderna COVID‑19 vaccine is used to provide protection against infection by the SARS‑CoV‑2 virus in order to prevent COVID‑19. [42][2] The vaccine is given by intramuscular injection into the deltoid muscle of the arm. [33] The initial course consists of …
Moderna COVID-19 Vaccine Summary | Vaccines & Immunizations …
WEBAug 28, 2024 · Moderna COVID-19 Vaccine 2024-2025 Formula is indicated for people 6 months through 11 years of age. Moderna SPIKEVAX ® is indicated for people 12 years and older.
Moderna COVID-19 Vaccine | FDA
WEBNov 1, 2023 · Information about Moderna COVID-19 Vaccine, Bivalent. Updated, bivalent mRNA COVID-19 vaccines are now FDA-authorized for all doses for individuals ages 6 months and older.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 · The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech...
Moderna's COVID-19 Vaccine: What You Need to Know
WEBApr 30, 2024 · The Moderna vaccine is an mRNA vaccine, similar to the one developed by Pfizer. The technology behind these vaccines has been around for about three decades and shown promise in preventing notoriously difficult-to-prevent diseases—even cancer.
The Moderna COVID-19 (mRNA-1273) vaccine: what you need …
WEBAug 18, 2022 · For adults aged 17 and above, SAGE recommends the use of the Moderna mRNA-1273 vaccine at a schedule of two doses (100 µg, 0.5 ml each) 8 weeks apart. For adolescents aged 12 to 17 years, SAGE recommends 2 doses (100 µg, 0.5 ml each), given intramuscularly, 4 weeks apart.
Pioneering mRNA technology - Moderna
WEBSPIKEVAX® (COVID-19 Vaccine, mRNA) 2024-2025 Formula is now FDA approved. Learn more
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
WEBDec 30, 2020 · The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease. Aside from transient local and systemic reactions, no safety concerns were identified.
How Moderna’s Covid-19 Vaccine Works - The New York Times
WEBModerna, a Massachusetts-based vaccine developer, partnered with the National Institutes of Health to develop and test a coronavirus vaccine known as mRNA-1273. A clinical trial...
Statement from NIH and BARDA on the FDA Emergency Use …
WEBDec 18, 2020 · The vaccine, called mRNA-1273, is a messenger RNA (mRNA) vaccine against COVID-19 encoding a prefusion stabilized form of the spike protein of SARS-CoV-2, co-developed by investigators from Moderna and NIAID’s Vaccine Research Center.